Introducing our 2025 Moment of the Year: Opening Elanco’s Future. In October 2025, we officially opened the doors at our new global headquarters in Indianapolis. Medical Mutts Service Dogs', Indy, helped us “bite” the ribbon to welcome guests and team members into our new space. The Elanco US Pet Health team sponsored Indy’s training and adoption, and she exemplifies the important bond between humans and animals. This moment was captured in oil on canvas by Indianapolis artist Rebeka Anastasia Sweetland. Rebeka’s work often expresses “transitional momentum” and moments of impact, making her the perfect choice to capture our 2025 Moment of the Year.
This week, Elanco CEO Jeff Simmons participated in the Animal Health, Nutrition and Technology Innovation Conference, a premier forum connecting biotech innovators, investors, and global leaders to drive the future of the Animal Health industry. Thank you to the organizers for hosting such vital conversations. See the highlights below from Jeff's remarks on the crossroads moment facing our industry and our path to a $60B future.
Scratching, rubbing, chewing, licking. All signs of an irritated, itchy dog. Today, Elanco Animal Health Incorporated (NYSE: ELAN), is introducing some of the first allergic dogs who have found zen and gotten back to normal by using Zenrelia. Zenrelia, which was approved by the U.S. Food and Drug Administration (FDA) and launched in September 2024, is a highly effective, convenient and safe once-daily oral JAK inhibitor for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest Parasite Protection of Its Kind. Credelio Quattro is the first and only monthly chewable tablet of its kind to protect against six different types of parasites, including three risky intestinal worms that can be passed to humans.
At Elanco, we believe that a healthy world starts with healthy animals. Our commitment to animal health extends beyond providing safe and effective products. It also involves nurturing the next generation of researchers and scientists who will drive the future of animal health. That's why we have established the Elanco Scholars Program, which links individuals within our talent programs as interns, post-doctoral scientists, and Fellows with additional training, networking and career development opportunities.
At Elanco, we believe that a healthy world starts with healthy animals. Our commitment to animal health extends beyond providing safe and effective products. It also involves nurturing the next generation of researchers and scientists who will drive the future of animal health. That's why we have established the Elanco Scholars Program, which links individuals within our talent programs as interns, post-doctoral scientists, and Fellows with additional training, networking and career development opportunities.
Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest Parasite Protection of Its Kind. Credelio Quattro is the first and only monthly chewable tablet of its kind to protect against six different types of parasites, including three risky intestinal worms that can be passed to humans.
Scratching, rubbing, chewing, licking. All signs of an irritated, itchy dog. Today, Elanco Animal Health Incorporated (NYSE: ELAN), is introducing some of the first allergic dogs who have found zen and gotten back to normal by using Zenrelia. Zenrelia, which was approved by the U.S. Food and Drug Administration (FDA) and launched in September 2024, is a highly effective, convenient and safe once-daily oral JAK inhibitor for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
25,000. That’s how many hours our global team has committed to volunteering by 2025. Last year, our team recorded more than 23,600 volunteer hours supporting causes to improve animal welfare, community services, food security and education worldwide. But that’s just the start. Officially one month out from our annual Global Day of Purpose- an event to kick off a month of giving and volunteerism- our team is gearing up to make this year our biggest yet! hashtag#WeAreElanco hashtag#GDOP2024
We're continually striving to engage with a variety of industry groups and organizations to further drive and support diversity, equity and inclusion with a culture that fosters a sense of belonging and brings our inclusive culture to life. Our Elanco Innovation and Alliance Center (IAC) in India was recently awarded with six company awards and one individual award at the AcellHerate and DivHERsity Awards 2024, the largest DE&I summit in India that has more than 350 companies participating. The IAC team was awarded as a “Top 5 Company in divHERsity” along with being recognized among the “Top 20 Most Innovative Practices” in five categories: DivHERsity Policies, Women Returnee Programs, Women L&D Programs, Women Leadership Development and DivHERsity Programs. Also recognized was Mukta Arora for an individual award as a “Top 5 Diversity Champion”.
